[ Price : $8.95]
Federal Register notice: FDA announces the renewal of its Bone, Reproductive and Urologic Drugs Advisory Committee for an addition...[ Price : $8.95]
FDA grants Lexicon Pharmaceuticals a fast track designation for LX9211 and its use in treating diabetic peripheral neuropathic pai...[ Price : $8.95]
Sanofi and GlaxoSmithKline delay their Covid-19 vaccine program to improve immune response in older adults.[ Price : $8.95]
FDA grants an emergency use authorization for Pfizer-BioNTechs Covid-19 vaccine amid a White House threat for commissioner Stephen...[ Price : $8.95]
FDA grants ReCor Medical a breakthrough device designation for Paradise Ultrasound Renal Denervation System and its use for treati...[ Price : $8.95]
FDA posts three new guidances for device makers to use under its Safety and Performance-Based Pathway.[ Price : $8.95]
FDA grants X4 Pharmaceuticals a rare pediatric disease designation for mavorixafor for treating WHIM (Warts, Hypogammaglobulinemia...[ Price : $8.95]
FDA accepts for filing an Atox Bio NDA for reltecimod to treat patients with necrotizing soft tissue infections.